Team:Virtus-Parva Mexico/Safety
From 2014.igem.org
(11 intermediate revisions not shown) | |||
Line 54: | Line 54: | ||
<!-- Block of content 1 --> | <!-- Block of content 1 --> | ||
<table width="100%" cellspacing="0" height="500px" border="0"> | <table width="100%" cellspacing="0" height="500px" border="0"> | ||
- | <tr><td bgColor="# | + | <tr><td bgColor="#8AAA3D"></td> |
- | <td width="975px" align="left" bgColor="# | + | <td width="975px" align="left" bgColor="#8AAA3D" > |
<table width="975px" cellspacing="0" height="500px" border="0"> | <table width="975px" cellspacing="0" height="500px" border="0"> | ||
<tr> | <tr> | ||
- | <td width="95%" bgColor="# | + | <td width="95%" bgColor="#8AAA3D" rowspan="3" align="left"> |
Line 72: | Line 72: | ||
</td> | </td> | ||
<!-- This is the back to top button --> | <!-- This is the back to top button --> | ||
- | <td bgColor=# | + | <td bgColor=#8AAA3D> </td> |
- | <tr><td bgColor=# | + | <tr><td bgColor=#8AAA3D></td></tr> |
- | <tr> <td height=" | + | <tr> <td height="50px" width="5%" align="center" bgColor=#8AAA3D> |
- | <a href="#menu" style="text-decoration:none;color:#1C140D"> | + | <a href="#menu" style="text-decoration:none;color:#1C140D"><img src="https://static.igem.org/mediawiki/2014/3/39/Virtus_Parva-TOP-v2.jpg"></img></a> </td></tr> |
</table> | </table> | ||
</td> | </td> | ||
- | <td bgColor="# | + | <td bgColor="#8AAA3D"></td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 97: | Line 97: | ||
<br> | <br> | ||
<p align="justify"><font size=4 color="#ffffff"> | <p align="justify"><font size=4 color="#ffffff"> | ||
- | Question 1: Would any of your project idea raise safety <br> | + | <i>Question 1: Would any of your project idea raise safety <br> |
issues in terms of research safety, public safety or <br> | issues in terms of research safety, public safety or <br> | ||
- | environmental safety?<br> | + | environmental safety?</i><br> |
<br> | <br> | ||
The strain of E. Coli we chose to work with, DSM <br> | The strain of E. Coli we chose to work with, DSM <br> | ||
Line 114: | Line 114: | ||
<br> | <br> | ||
<br> | <br> | ||
- | Question 2: Are any parts or devices in our project <br> | + | <i>Question 2: Are any parts or devices in our project <br> |
associated with (or known to cause) pathogenicity, <br> | associated with (or known to cause) pathogenicity, <br> | ||
infectivity, toxicity, threats to environmental quality<br> | infectivity, toxicity, threats to environmental quality<br> | ||
- | or security concerns? | + | or security concerns?</i> |
- | <br> | + | <br><br> |
The biggest risk comes from E. Coli infections to our <br> | The biggest risk comes from E. Coli infections to our <br> | ||
team handling bacteria, an issue for which we have <br> | team handling bacteria, an issue for which we have <br> | ||
Line 134: | Line 134: | ||
</td> | </td> | ||
<td bgColor="#355079"><img src="https://static.igem.org/mediawiki/2014/e/ea/Virtus_Parva_Abraham_saftey.jpg"/></td><td width="162px" bgColor="#355079"></td></tr></table> | <td bgColor="#355079"><img src="https://static.igem.org/mediawiki/2014/e/ea/Virtus_Parva_Abraham_saftey.jpg"/></td><td width="162px" bgColor="#355079"></td></tr></table> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 173: | Line 157: | ||
- | <p> <font size=4> Question 3: Do any of the new BioBricks parts (or devices) that you made this year raise any safety issues? | + | <p> <font size=4><font color=#FFFFFF><i> Question 3: Do any of the new BioBricks parts (or devices) that you made this year raise any safety issues?</i> |
<br> | <br> | ||
We do not use any BioBricks parts this year, we have designed a device that only affects bacterial systems. | We do not use any BioBricks parts this year, we have designed a device that only affects bacterial systems. | ||
Line 186: | Line 170: | ||
<td bgColor=#8AAA3D </td> | <td bgColor=#8AAA3D </td> | ||
<tr><td bgColor=#8AAA3D></td></tr> | <tr><td bgColor=#8AAA3D></td></tr> | ||
- | <tr> <td height=" | + | <tr> <td height="50px" width="5%" align="center" bgColor=#8AAA3D> |
- | <a href="# | + | <a href="#menu" style="text-decoration:none;color:#1C140D"><img src="https://static.igem.org/mediawiki/2014/3/39/Virtus_Parva-TOP-v2.jpg"></img></a> </td></tr> |
</table> | </table> | ||
</td> | </td> | ||
Line 200: | Line 184: | ||
<tr><td bgColor=#F45D4C ></td></tr> | <tr><td bgColor=#F45D4C ></td></tr> | ||
<tr> <td height="20px" width="5%" align="center" onMouseOver="this.bgColor='#FFFFFF'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <tr> <td height="20px" width="5%" align="center" onMouseOver="this.bgColor='#FFFFFF'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
- | <a href="#menu" style="text-decoration:none;color:#1C140D"> | + | <a href="#menu" style="text-decoration:none;color:#1C140D"></a> </td></tr> |
</table> | </table> |
Latest revision as of 03:31, 18 October 2014
Our Questions
Question 1: Would any of your project idea raise safety |
|
|